Ledger.Open graph →
SEC Form D · filed January 8, 2025

Bambusa Therapeutics, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Helmut Jeggle · Boston, MADirectorShanshan Xu · Boston, MAExec · Director · PromoterShanshan Xu · Boston, MAExec · Director · PromoterHelmut Jeggle · Boston, MADirectorTeisha Vandekop · Meridian, TXDirectorGary Tickel · San Marino, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗